
Vegacef S 500mg/250mg Injection
Marketer
Adley Formulations
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Vegacef S 500mg/250mg Injection
Cefixime and Sulbactam injection (500mg/250mg), marketed as Vegacef S, combats various bacterial infections by inhibiting microbial growth and spread. Administration must be overseen by a healthcare provider. Complete the prescribed course, even with symptom improvement; premature cessation may reduce effectiveness. Common side effects include nausea, vomiting, diarrhea, and indigestion. Severe side effects or allergic reactions (rash, itching, swelling, breathing difficulty) require immediate medical attention. Inform your physician of all current medications, including those for pre-existing conditions, before use. Pregnant or lactating individuals should consult their doctor. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, avoid driving if drowsiness or dizziness occurs. Adequate rest, healthy nutrition, and hydration aid recovery. Your doctor may order lab tests to monitor treatment response.
Primary Ingredients of Vegacef S 500mg/250mg Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Vegacef S 500mg/250mg Injection
Infections caused by bacteria
Major Benefits of Vegacef S 500mg/250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Vegacef S 500mg/250mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Vegacef S 500mg/250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Vegacef S 500mg/250mg Injection works:
Ceftriaxone/Sulbactam injection (Vegacef S 500mg/250mg) unites a cephalosporin antibiotic (Ceftriaxone) with a beta-lactamase inhibitor (Sulbactam). Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, thus hindering bacterial proliferation. Sulbactam counters bacterial resistance mechanisms, augmenting Ceftriaxone's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Vegacef S 500mg/250mg Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Vegacef S (500mg/250mg) is typically deemed safe for use during pregnancy. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
Administering Vegacef S 500mg/250mg Injection to breastfeeding mothers requires careful consideration. Breastfeeding is advised against until maternal treatment concludes and the medication is fully cleared from the mother's system.
DrivingUNSAFE
Administration of Vegacef S 500mg/250mg Injection can induce drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Vegacef S 500mg/250mg Injection to individuals with renal impairment. Physician consultation is recommended.
LiverCAUTION
The injectable formulation Vegacef S (500mg/250mg) requires careful administration in individuals with advanced hepatic impairment. Dosage modification of Vegacef S (500mg/250mg) injection may be necessary. Medical advice is recommended. Altering the dosage of Vegacef S (500mg/250mg) injection is not advised for patients experiencing mild to moderate liver dysfunction.
What if you forget to take Vegacef S 500mg/250mg Injection :
Should you inadvertently skip a dose of Vegacef S 500mg/250mg Injection, seek medical advice.
Facts to Know About Vegacef S 500mg/250mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Infectious Disease Treatments |
